Search research articles
Contact Us
Filters
Showing results (11-20 of 29) with videos related to
Page
of 3
Sort By:
Oncogene
|
June 23, 2009
SOCS-mediated downregulation of mutant Jak2 (V617F, T875N and K539L) counteracts cytokine-independent signaling
S Haan, S Wüller, J Kaczor, et al.
The Biochemical Journal
|
January 22, 2000
Cytoplasmic STAT proteins associate prior to activation
S Haan, M Kortylewski, I Behrmann, et al.
FEBS Letters
|
March 21, 2000
Termination of IL-6-induced STAT activation is independent of receptor internalization but requires de novo protein synthesis
S Thiel, U Sommer, M Kortylewski, et al.
The EMBO Journal
|
November 15, 1995
Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor
F C Kischkel, S Hellbardt, I Behrmann, et al.
The Biochemical Journal
|
April 16, 1998
Internalization of the interleukin 6 signal transducer gp130 does not require activation of the Jak/STAT pathway
S Thiel, I Behrmann, E Dittrich, et al.
FEBS Letters
|
August 3, 2000
Differential inhibition of IL-6-type cytokine-induced STAT activation by PMA
L Terstegen, B G Maassen, S Radtke, et al.
FEBS Letters
|
September 15, 2001
A region encompassing the FERM domain of Jak1 is necessary for binding to the cytokine receptor gp130
C M Hilkens, H Is'harc, B F Lillemeier, et al.
Blood
|
July 27, 2001
STAT3 is constitutively activated in Hodgkin cell lines
D Kube, U Holtick, M Vockerodt, et al.
Oncogene
|
July 3, 1999
Interleukin-6 and oncostatin M-induced growth inhibition of human A375 melanoma cells is STAT-dependent and involves upregulation of the cyclin-dependent kinase inhibitor p27/Kip1
M Kortylewski, P C Heinrich, A Mackiewicz, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
December 10, 1999
Contributions of leukemia inhibitory factor receptor and oncostatin M receptor to signal transduction in heterodimeric complexes with glycoprotein 130
H M Hermanns, S Radtke, C Haan, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 29) with videos related to
Sort By:
Page
of 3
Oncogene
|
June 23, 2009
SOCS-mediated downregulation of mutant Jak2 (V617F, T875N and K539L) counteracts cytokine-independent signaling
S Haan, S Wüller, J Kaczor, et al.
The Biochemical Journal
|
January 22, 2000
Cytoplasmic STAT proteins associate prior to activation
S Haan, M Kortylewski, I Behrmann, et al.
FEBS Letters
|
March 21, 2000
Termination of IL-6-induced STAT activation is independent of receptor internalization but requires de novo protein synthesis
S Thiel, U Sommer, M Kortylewski, et al.
The EMBO Journal
|
November 15, 1995
Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor
F C Kischkel, S Hellbardt, I Behrmann, et al.
The Biochemical Journal
|
April 16, 1998
Internalization of the interleukin 6 signal transducer gp130 does not require activation of the Jak/STAT pathway
S Thiel, I Behrmann, E Dittrich, et al.
FEBS Letters
|
August 3, 2000
Differential inhibition of IL-6-type cytokine-induced STAT activation by PMA
L Terstegen, B G Maassen, S Radtke, et al.
FEBS Letters
|
September 15, 2001
A region encompassing the FERM domain of Jak1 is necessary for binding to the cytokine receptor gp130
C M Hilkens, H Is'harc, B F Lillemeier, et al.
Blood
|
July 27, 2001
STAT3 is constitutively activated in Hodgkin cell lines
D Kube, U Holtick, M Vockerodt, et al.
Oncogene
|
July 3, 1999
Interleukin-6 and oncostatin M-induced growth inhibition of human A375 melanoma cells is STAT-dependent and involves upregulation of the cyclin-dependent kinase inhibitor p27/Kip1
M Kortylewski, P C Heinrich, A Mackiewicz, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
December 10, 1999
Contributions of leukemia inhibitory factor receptor and oncostatin M receptor to signal transduction in heterodimeric complexes with glycoprotein 130
H M Hermanns, S Radtke, C Haan, et al.
Page
of 3